Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
|NCT02124512||2014-12-01||Blood Lipopolysaccharide (LPS) Rifaximin Study||Phase 2||Not Yet Recruiting|
|NCT01904409||2013-06-01||Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis||Phase 2||Active, Not Recruiting|
|NCT00280228||2006-01-01||Home Based Treatment for Drug Use in Early Adolescents||Phase 2||Completed|